Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 26, 2019
Medicon Valley Alliance

BioInnovation Institute (BII) joins the global CARB-X network to accelerate start-ups in drug-resistant infections

An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which is now expanding its Global Accelerator Network to include among others BII.

BioInnovation Institute (BII) joins the global CARB-X network to accelerate start-ups in drug-resistant infections

An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which is now expanding its Global Accelerator Network to include among others BII.

An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which is now expanding its Global Accelerator Network to include among others BII.

“By joining the network, BioInnovation Institute commits to support international CARB-X companies in their development through Phase 1. At BioInnovation Institute, they will have access to our 2300 m2 state-of-the-art labs and office space, high-level mentors and experts, a thriving entrepreneurial community and networks in the heart of Medicon Valley, one of Europe’s leading life science clusters,” says Jens Nielsen, CEO at BioInnovation Institute.

The first CARB-X BioInnovation Institute collaborations are expected to start in the summer of 2019. Read full article in today´s online edition of “European Biotechnology“.

Last updated:
February 26, 2019

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

An estimated 700,000 people die each year worldwide from bacterial infections. New antibiotics, rapid diagnostics, vaccines and other products are urgently needed to treat bacteria that are increasingly resistant to existing antibiotics. This is the challenge adressed by the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which is now expanding its Global Accelerator Network to include among others BII.

“By joining the network, BioInnovation Institute commits to support international CARB-X companies in their development through Phase 1. At BioInnovation Institute, they will have access to our 2300 m2 state-of-the-art labs and office space, high-level mentors and experts, a thriving entrepreneurial community and networks in the heart of Medicon Valley, one of Europe’s leading life science clusters,” says Jens Nielsen, CEO at BioInnovation Institute.

The first CARB-X BioInnovation Institute collaborations are expected to start in the summer of 2019. Read full article in today´s online edition of “European Biotechnology“.

Last updated:
February 26, 2019

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail